{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:30:22Z","timestamp":1777930222058,"version":"3.51.4"},"reference-count":0,"publisher":"S. Karger AG","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Onkologie"],"abstract":"<jats:p>Es wird \u00fcber 15 F\u00e4lle vom Mammakarzinom beim Mann berichtet, welche im Zeitraum von 1972 bis 1988 an der chirurgischen Abteilung des Hanusch-Krankenhauses in Wien behandelt wurden. Das Durchschnittsalter der Patienten betrug 61,7 Jahre (38\u201382). Bei einer mittleren Beobachtungszeit von 40 Monaten (1\u2013171 Monate) sind zwei Drittel der Patienten verstorben, davon 40% an der Grundkrankheit. Bei Fallen mit mehr als 5j\u00e4hriger Beobachtungszeit lebt lediglich 1 von 11 Patienten, 6 davon kamen allerdings interkurrent ad exitum. Als Erstsymptom fand sich in 40 % der F\u00e4lle ein schmerzhafter Knoten bei begleitender Gyn\u00e4komastie. 7 von 15 (= 46,6%) der Patienten sind mit Aldosteron-Antagonisten vom Spironolactontyp behandelt worden. Risikofaktoren f\u00fcr das Mammakarzinom beim Mann kamen bis auf eine anamnestisch bekannte R\u00f6ntgenbestrahlung nicht zur Beobachtung. Eine zentrale Erfassung und Verarbeitung multizentrisch eingebrachter Daten f\u00fcr dieses seltene Krankheitsbild erscheint uns zwecks Evaluierung optimaler Therapieregimes w\u00fcnschenswert.<\/jats:p>","DOI":"10.1159\/000216739","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T10:05:34Z","timestamp":1240999534000},"page":"128-131","source":"Crossref","is-referenced-by-count":3,"title":["Mammakarzinom beim Mann \u2013 Eine retrospektive Analyse von 15 F\u00e4llen"],"prefix":"10.1159","author":[{"given":"M.","family":"Stierer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Spoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.R.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2009,4,28]]},"container-title":["Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/216739","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000216739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T00:07:18Z","timestamp":1777680438000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000216739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1159\/000216739","archive":["Portico"],"relation":{},"ISSN":["0378-584X","1423-0240"],"issn-type":[{"value":"0378-584X","type":"print"},{"value":"1423-0240","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}